Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2025 ,inter alia, to consider and approve the financial results of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience has postponed its Board of Directors meeting originally scheduled for July 19, 2025, and it will now be held on July 24, 2025. The board was set to consider and approve the financial results for the period ended March 31, 2025. The company cited unforeseen and unavoidable circumstances as the reason for the postponement. The trading window for designated persons remains closed from April 1, 2025 until July 26, 2025. No financial details, numbers, or outcomes have been disclosed in this intimation.
This is a procedural update with no direct impact on shareholders; investors should await the actual financial results when announced on or after July 24, 2025. Postponements of board meetings can sometimes create minor uncertainty but do not alter the company's fundamentals.